Table 1.
2000-2009 (col %) | 2010-2014 (col %) | 2015-2016 (col %) | 2017-2018 (col %) | |
---|---|---|---|---|
Total PWID achieving SVR∗ | 886 | 1,587 | 1,426 | 1,787 |
NHS board of treatment | ||||
Greater Glasgow and Clyde | 410 (46.3) | 863 (54.4) | 854 (59.9) | 1,102 (61.7) |
Grampian/Lothian | 331 (37.4) | 421 (26.5) | 346 (24.3) | 341 (19.1) |
Tayside | 145 (16.4) | 303 (19.1) | 226 (15.8) | 344 (19.3) |
Treatment setting | ||||
Hospital | 206 (23.3) | 1,109 (69.9) | 1,059 (74.3) | 983 (55.0) |
Community | 7 (0.8) | 227 (14.3) | 259 (18.2) | 682 (38.2) |
Prison | 11 (1.2) | 125 (7.9) | 105 (7.4) | 122 (6.8) |
Other/not known∗∗ | 662 (74.7) | 126 (7.9) | 3 (0.2) | 0 (0.0) |
Sex | ||||
Female | 235 (26.5) | 349 (22.0) | 319 (22.4) | 452 (25.3) |
Male | 651 (73.5) | 1,238 (78.0) | 1,107 (77.6) | 1,335 (74.7) |
Age (years) | ||||
50+ | 86 (9.7) | 227 (14.3) | 438 (30.7) | 467 (26.1) |
35-49 | 498 (56.2) | 884 (55.7) | 806 (56.5) | 1,098 (61.4) |
<35 | 302 (34.1) | 476 (30.0) | 182 (12.8) | 222 (12.4) |
Treatment regimen | ||||
Interferon-based | 882 (99.5) | 1,522 (95.9) | 444 (31.1) | 28 (1.6) |
Interferon-free | 0 (0.0) | 57 (3.6) | 982 (68.9) | 1,759 (98.4) |
Other/not known | 4 (0.5) | 8 (0.5) | 0 (0.0) | 0 (0.0) |
Cirrhosis at time of treatment | ||||
No | 820 (92.6) | 1,291 (81.3) | 971 (68.1) | 1,462 (81.8) |
Yes | 66 (7.4) | 296 (18.7) | 455 (31.9) | 325 (18.2) |
Opioid/injection hospital admission | ||||
>3 years pre-treatment/never pre-Treatment | 771 (87.0) | 1,285 (81.0) | 1,124 (78.8) | 1,272 (71.2) |
During treatment/in the 3 years pre-treatment | 115 (13.0) | 302 (19.0) | 302 (21.2) | 515 (28.8) |
NHS, National Health Service; PWID, people who inject drugs; SVR, sustained virological response.
Achieved SVR according to the Scottish HCV clinical database. Patients can achieve SVR more than once if they were reinfected.
Whilst treatment setting was not recorded on the clinical database during 2000-2009, the vast majority would have been hospital.